M Gómez-Cano

601 total citations
13 papers, 420 citations indexed

About

M Gómez-Cano is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, M Gómez-Cano has authored 13 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 10 papers in Virology and 4 papers in Molecular Biology. Recurrent topics in M Gómez-Cano's work include HIV Research and Treatment (10 papers), HIV/AIDS drug development and treatment (9 papers) and HIV/AIDS Research and Interventions (6 papers). M Gómez-Cano is often cited by papers focused on HIV Research and Treatment (10 papers), HIV/AIDS drug development and treatment (9 papers) and HIV/AIDS Research and Interventions (6 papers). M Gómez-Cano collaborates with scholars based in Spain and Japan. M Gómez-Cano's co-authors include Vincent Soriano, Bonaventura Clotet, Mayte Pérez‐Olmeda, Amalia Rubio, Teresa Puig, Laura Zamora, Lı́dia Ruiz, Manuel Leal, Juan A. Pineda and África Holguín and has published in prestigious journals such as International Journal of Molecular Sciences, The Journal of Infectious Diseases and AIDS.

In The Last Decade

M Gómez-Cano

12 papers receiving 398 citations

Peers

M Gómez-Cano
Charvi Patel United States
Adeline Nukuna United States
Shawna M. Woollard United States
Rebecca T. Veenhuis United States
Ann Atlas Sweden
Louise Evans Australia
Jadwiga Nitkiewicz United States
Claire Veryard United Kingdom
Charvi Patel United States
M Gómez-Cano
Citations per year, relative to M Gómez-Cano M Gómez-Cano (= 1×) peers Charvi Patel

Countries citing papers authored by M Gómez-Cano

Since Specialization
Citations

This map shows the geographic impact of M Gómez-Cano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Gómez-Cano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Gómez-Cano more than expected).

Fields of papers citing papers by M Gómez-Cano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Gómez-Cano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Gómez-Cano. The network helps show where M Gómez-Cano may publish in the future.

Co-authorship network of co-authors of M Gómez-Cano

This figure shows the co-authorship network connecting the top 25 collaborators of M Gómez-Cano. A scholar is included among the top collaborators of M Gómez-Cano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Gómez-Cano. M Gómez-Cano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Mena, Rocío, Carmen Rodríguez Jiménez, Ángela del Pozo, et al.. (2023). Whole Exome Sequencing of 20 Spanish Families: Candidate Genes for Non-Syndromic Pediatric Cataracts. International Journal of Molecular Sciences. 24(14). 11429–11429. 4 indexed citations
2.
Arteche‐López, Ana, M Gómez-Cano, Juan Francisco Quesada‐Espinosa, et al.. (2022). Expanding the Phenotypic Spectrum of Alazami Syndrome: Two Unrelated Spanish Families. Neuropediatrics. 54(1). 31–36. 1 indexed citations
3.
Puig, Teresa, Mayte Pérez‐Olmeda, Amalia Rubio, et al.. (2000). Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain. AIDS. 14(6). 727–732. 55 indexed citations
4.
Gómez-Cano, M, et al.. (1999). Multiple Drug Resistance Genotype Causing Failure of Antiretroviral Treatment in an HIV-Infected Patient Heavily Exposed to Nucleoside Analogues. European Journal of Clinical Microbiology & Infectious Diseases. 18(5). 372–375. 11 indexed citations
5.
Pérez‐Olmeda, Mayte, Amalia Rubio, Teresa Puig, et al.. (1999). Evolution of Genotypic Resistance to Nucleoside Analogues in Patients Receiving Protease Inhibitor-Containing Regimens. Antiviral Therapy. 4(3). 179–181. 7 indexed citations
6.
Rubio, Amalia, M Gómez-Cano, Teresa Puig, et al.. (1999). Presence of Genotypic Resistance in Nucleoside Analogue-Treated HIV-1-Infected Patients with Undetectable Viral Load. Antiviral Therapy. 4(1). 45–49. 16 indexed citations
7.
Gómez-Cano, M, Amalia Rubio, Lidia Ruíz, et al.. (1999). Efficiency of Drug Resistance Genotypic Tests in Specimens with Low HIV Viral Load. Antiviral Therapy. 4(2). 123–124. 11 indexed citations
8.
Soriano, Vincent, Jesús Castilla, M Gómez-Cano, et al.. (1998). The decline in CD4+ T lymphocytes as a function of the duration of HIV infection, age at seroconversion, and viral load. Journal of Infection. 36(3). 307–311. 14 indexed citations
9.
Yamamoto, Shinji, M Gómez-Cano, Vincent Soriano, et al.. (1998). Measurement of Human Immunodeficiency Virus Type 1 Plasma Virus Load Based on Reverse Transcriptase (RT) Activity: Evidence of Variabilities in Levels of Virion‐Associated RT. The Journal of Infectious Diseases. 177(5). 1221–1229. 32 indexed citations
10.
Casas, E, et al.. (1998). [Combined antiretroviral therapy for prevention of vertical HIV-1 transmission].. PubMed. 15(3). 148–51. 1 indexed citations
11.
Gómez-Cano, M, Amalia Rubio, Teresa Puig, et al.. (1998). Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain. AIDS. 12(9). 1015–1020. 263 indexed citations
12.
Gómez-Cano, M, Antonio Más, Jesús Castilla, et al.. (1997). [Quantification of viremia in patients infected with human immunodeficiency virus with different degrees of immunosuppression].. PubMed. 197(12). 810–3. 1 indexed citations
13.
Soriano, Vincent, et al.. (1997). Short-term efficacy and safety of stavudine in pretreated HIV-infected patients.. PubMed. 2(3). 185–9. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026